PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of NanoMedicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095, United States.\', \'California NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States.\', \'Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, California 90095, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acsnano.1c01845
?:hasPublicationType
?:journal
  • ACS nano
is ?:pmid of
?:pmid
?:pmid
  • 33793189
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.203
?:rankingScore_hIndex
  • 277
is ?:relation_isRelatedTo_publication of
?:title
  • Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33793189>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33793189>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all